him and hers stock: Guide to Hims & Hers (HIMS)

Hims & Hers Health, Inc. (HIMS)

As an entry point, this guide explains everything a reader needs to know about him and hers stock (the publicly traded Hims & Hers Health, Inc., ticker HIMS). If you are new to telehealth equities or researching direct-to-consumer healthcare companies, this article will define the company, summarize its history, outline products and revenue drivers, cover governance and market information, and list primary sources for up-to-date market metrics. The outline below is neutral, fact-focused, and avoids investment advice.

Note: the exact market numbers for him and hers stock change daily. As of 2026-01-27, readers should verify live price and volume on major finance portals and the company’s investor relations materials. For example, as of 2026-01-27, according to Yahoo Finance and company releases, market metrics and trading volumes are available on those platforms for real-time verification.

Company overview

Hims & Hers Health, Inc. is a U.S.-based telehealth and consumer health company that operates digital-first brands providing access to licensed healthcare providers, prescription and over-the-counter products, and wellness services. In market contexts, him and hers stock refers to shares of Hims & Hers Health that trade on the New York Stock Exchange under the ticker symbol HIMS.

The company’s mission centers on lowering barriers to basic healthcare and wellness for adults through a technology-enabled, direct-to-consumer platform. Core consumer-facing brands include Hims (traditionally male-focused product lines) and Hers (female-focused product lines), alongside adjacent services and specialty offerings. The platform integrates telemedicine consultations, clinical protocols, pharmacy fulfillment, and recurring product subscriptions to serve sexual health, hair loss, skin care, mental health, and weight management needs.

As a digital-first healthcare provider, Hims & Hers emphasizes convenience, privacy, and integrated fulfillment logistics. Its model combines virtual clinical intake, provider-driven prescriptions or recommendations, and pharmacy or third-party lab fulfillment channels to deliver end-to-end consumer experiences.

History

Founding and early growth

Hims & Hers began as a direct-to-consumer health brand aimed at simplifying access to common medical treatments and wellness products. Initial product categories focused on sexual health, hair loss, and skincare, leveraging telemedicine to connect consumers with licensed clinicians who could prescribe medications or recommend OTC products. Early growth relied heavily on digital marketing, subscription models, and fulfillment partnerships to scale repeat revenue.

Public listing

In public market contexts, him and hers stock refers to the company’s NYSE listing under HIMS. The company’s path to the public markets and subsequent capital-raising activities enabled wider brand expansion, new product lines, and increased investment in technology and fulfillment infrastructure. As with any public company discussion, investors and researchers should consult the firm’s SEC filings and investor relations materials for precise dates and transaction details.

Major corporate events and expansion

Over time, Hims & Hers expanded beyond its initial product mix to include telehealth services for mental health, diagnostics and lab testing add-ons, weight-management programs, and additional skincare and wellness categories. The company has executed strategic partnerships and pursued acquisitions to extend its healthcare capabilities and geographic footprint. Geographic expansion efforts have included entry into markets beyond the U.S. (for example, Canada) and integrations with lab and pharmacy service providers.

Significant corporate milestones in the company’s timeline typically appear in press releases and quarterly investor presentations; readers researching him and hers stock should review the company’s recent 10-Q and 8-K filings to confirm transaction and expansion specifics.

Business model and products

Core offerings

Hims & Hers operates multiple consumer-facing product lines and services, including:

• Telehealth consultations: virtual visits or medical intake forms reviewed by licensed clinicians who can diagnose, recommend treatment, and prescribe when appropriate.
• Prescription services: recurring or one-off prescriptions for approved conditions (sexual health medications, certain dermatology or hair treatments, etc.).
• Over-the-counter products: skincare, supplements, and wellness items sold directly to consumers.
• Mental health services: therapy and counseling offerings through digital platforms or partner clinicians.
• Weight-management and metabolic care: structured programs that may include medication, coaching, and monitoring tools.
• Diagnostics and labs: at-home test kits and integration with lab providers for clinical testing.

Each product line ties back to the platform’s ability to provide clinical intake, provider authorization, fulfillment via pharmacy partners, and recurring subscription billing when appropriate.

Platform elements

Key platform components for him and hers stock’s underlying business include:

• Digital medical records and intake workflows to collect relevant clinical history.
• A clinician network (licensed providers) that adheres to state and national telemedicine regulations.
• Pharmacy fulfillment and logistics, either through owned operations or third-party partners.
• Subscription and repeat-purchase models that drive customer lifetime value.
• Diagnostics integration for tests and lab results that inform care plans.

These elements create an ecosystem where clinical care, product manufacturing or sourcing, and fulfilment converge to support ongoing consumer relationships.

Revenue model

Revenue sources typically include product sales (one-time and recurring), subscription fees for programs, telehealth consultation fees (if separately billed), and diagnostic or lab revenues. The company sells directly through web and mobile channels and may generate incremental revenue from partnerships with other healthcare providers or employers. Advertising and cross-sales (upselling complementary products) also contribute to overall revenue.

Financials and stock market information

• Ticker and exchange: NYSE: HIMS (commonly referenced when discussing him and hers stock).

• Key financial indicators (overview): public summaries for him and hers stock report revenue growth rates, gross profit margins, and profitability metrics. These metrics vary quarterly; for precise figures (market capitalization, latest quarterly revenue, net income/loss, and valuation multiples such as price-to-sales or price-to-earnings where applicable), consult the company’s most recent 10-Q/10-K or reliable financial data providers.

• Share structure: him and hers stock has a typical public-company structure consisting of shares outstanding, free float, and institutional holdings. Specific counts for shares outstanding, float, and insider ownership percentages are disclosed in the company’s SEC filings and are tracked on financial data platforms.

As of 2026-01-27, according to company filings and major finance portals like Yahoo Finance and CNBC, up-to-date market capitalization, trading volume, and ownership metrics for him and hers stock can be found directly on those services or via the issuer’s investor relations page. Always confirm live figures prior to any decision-making or further research.

Stock performance and trading characteristics

Historical price range and volatility

Hims & Hers shares have experienced episodes of notable volatility—common for growth-oriented consumer and telehealth names—especially around product launches, earnings releases, regulatory news, or sector-wide developments (e.g., GLP-1 announcements and competitive changes). Researchers tracking him and hers stock should look at the 52-week high/low, beta, and implied volatility from options markets where applicable.

Liquidity and derivatives

HIMS is an exchange-listed equity that generally has tradable volume on U.S. exchanges. Options may be available, and average daily trading volume metrics are published on major market-data platforms. Liquidity characteristics influence bid/ask spreads and execution quality for large orders.

Market sentiment metrics

Market sentiment for him and hers stock can be inferred from short interest data, analyst ratings, and coverage notes published by brokerages. Coverage tends to be mixed for consumer telehealth stocks, where bullish views emphasize growth potential and recurring revenue while cautious views highlight competition, regulatory risks, and profitability timelines.

Corporate governance and management

Leadership and governance for him and hers stock include the chief executive officer, other named executives, and members of the board of directors. As an example of named leadership, Andrew Dudum has been publicly associated with Hims & Hers in a chief executive role. For accuracy on current management and board composition, refer to the company’s proxy statements and investor relations materials.

Insider activity in him and hers stock is publicly disclosed through SEC filings (Forms 3, 4, and 5) where executives and directors report transactions. Material insider transactions or changes in board composition are typically highlighted in 8-K filings.

Recent developments (notable news)

Below are categories of recent developments that materially affect public perception and trading of him and hers stock. Readers should check each item’s primary source (company press releases, SEC filings, or major financial news outlets) for precise dates and details.

• Product expansions: launches into new therapeutic categories (for example, expanded weight-management programs or new diagnostics) have been a recurring theme.
• Geographic expansion: entry into markets outside the U.S., such as Canada, is the type of milestone that impacts addressable market discussions.
• Corporate transactions: acquisitions of clinical, diagnostic, or telehealth technology providers strengthen the platform. Any acquisition that expands pharmacy, lab, or telemedicine capabilities would be covered in 8-K filings.
• Earnings and guidance: quarterly results and forward guidance announcements frequently move him and hers stock; such releases are available on the company’s investor relations site and in their 10-Q and 10-K filings.

As of 2026-01-27, according to CNBC and the company’s investor relations updates, recent quarters included commentary on product expansion and operational focus. Verify the exact items and dates by reviewing the firm’s most recent press releases and SEC documents.

Analyst coverage and investor sentiment

Credit and equity analysts at major brokerages and independent research firms periodically publish notes on him and hers stock. Typical coverage summarizes revenue trajectory, margins, user growth, and competitor comparisons. Analyst opinions typically range across buy/hold/sell and include target-price estimates; these positions evolve with new data and quarterly results.

Institutional investor interest—measured by 13F filings and large-holder disclosures—can influence trading volumes and price stability. A higher proportion of institutional ownership sometimes reduces volatility but can also create concentrated trading flows around earnings windows.

Risks and controversies

When evaluating him and hers stock, consider the following categories of risk that commonly appear in company filings and analyst write-ups. This list is not exhaustive and is intended to be factual and neutral:

• Competitive risk: the telehealth and consumer health markets are crowded with multiple entrants and established healthcare providers, creating pricing and customer-acquisition pressures.
• Regulatory risk: telemedicine is regulated at the state and federal level; changes in telehealth rules, prescription authority, or pharmacy laws could affect operations.
• Reimbursement and payer risk: changes in how medications or services are reimbursed (by insurers or governmental programs) may influence revenue streams.
• Customer-acquisition cost risk: heavy reliance on digital marketing can make the business sensitive to rising advertising costs and changing consumer acquisition dynamics.
• Product concentration and clinical risk: reliance on specific therapeutic categories or products can concentrate revenue and operational focus.
• Financial risks: margin pressure, cash burn, and leverage levels are cited in financial disclosures as potential constraints to growth.
• Legal and compliance risk: like other healthcare companies, Hims & Hers faces the possibility of regulatory inquiries or litigation related to clinical practices or product claims.

Readers looking at him and hers stock should review the company’s risk factors section in its annual report (10-K) for a detailed and current list of material risks.

Investor relations and reporting

Official sources for information on him and hers stock include the company’s investor relations website and the SEC EDGAR database for filings such as 10-Ks, 10-Qs, and 8-Ks. Routine investor materials—earnings releases, investor presentations, and recorded earnings calls—provide the primary factual basis for reporting on underlying business performance.

Shareholder actions such as buyback authorizations, dividend policy announcements (if any), or governance changes are typically disclosed in press releases and in SEC filings. For up-to-date corporate actions affecting him and hers stock, consult the company’s IR feed and official filings.

Where to find live market data

For live quotes, historical charts, and market metrics for him and hers stock, consult major financial data platforms and the company’s investor relations page. When discussing trading execution, Bitget is the recommended trading venue in this article’s platform context; Bitget supports equities and derivatives trading workflows and integrates wallet services for users active in digital-asset ecosystems. For custody or wallet needs related to Web3 interactions, Bitget Wallet is the recommended product.

Please note: this article does not provide trading or investment advice. It points to Bitget solely as the preferred platform contextually within this guide.

See also

• Telemedicine and virtual healthcare
• Direct-to-consumer (D2C) healthcare
• Digital pharmacy and fulfillment
• List of public telehealth companies
• NYSE-listed consumer healthcare equities

References and external links

Primary sources for him and hers stock information include (select the source and check the date-stamped content for the most recent updates):

• Company investor relations materials and SEC filings (10-K, 10-Q, 8-K)
• Yahoo Finance — Hims & Hers (HIMS) quote and company overview (as of 2026-01-27)
• CNBC — Hims & Hers profile and market coverage (as of 2026-01-27)
• TradingView and market-data platforms for historical charts and technical metrics
• Seeking Alpha and Simply Wall St for independent summaries and modeling

As of 2026-01-27, according to Yahoo Finance and CNBC reporting, live market metrics and trading statistics for him and hers stock are available on those services; consult them for day-of reporting and numerical facts.

Notes for editors

• Financial metrics and stock prices must be updated regularly. Use the company’s SEC filings and investor relations releases for primary-source verification of revenue, net income, and material corporate events.
• Avoid speculative claims about future performance. Present analyst views as sourced opinions and cite the originating firm and date.
• When including market numbers (market cap, average daily volume, shares outstanding, etc.), provide the data point, the reporting date, and the data source.